M A Perricone

Summary

Publications

  1. ncbi Aerosol and lobar administration of a recombinant adenovirus to individuals with cystic fibrosis. II. Transfection efficiency in airway epithelium
    M A Perricone
    Genzyme Corporation, Framingham, MA 01701, USA michael
    Hum Gene Ther 12:1383-94. 2001
  2. ncbi E4ORF3 requirement for achieving long-term transgene expression from the cytomegalovirus promoter in adenovirus vectors
    D Armentano
    Genzyme Corporation, Framingham, Massachusetts 01701 9322, USA
    J Virol 73:7031-4. 1999
  3. ncbi Inhibitory effect of cystic fibrosis sputum on adenovirus-mediated gene transfer in cultured epithelial cells
    M A Perricone
    Genzyme, Framingham, MA 01701, USA
    Hum Gene Ther 11:1997-2008. 2000

Detail Information

Publications3

  1. ncbi Aerosol and lobar administration of a recombinant adenovirus to individuals with cystic fibrosis. II. Transfection efficiency in airway epithelium
    M A Perricone
    Genzyme Corporation, Framingham, MA 01701, USA michael
    Hum Gene Ther 12:1383-94. 2001
    ....
  2. ncbi E4ORF3 requirement for achieving long-term transgene expression from the cytomegalovirus promoter in adenovirus vectors
    D Armentano
    Genzyme Corporation, Framingham, Massachusetts 01701 9322, USA
    J Virol 73:7031-4. 1999
    ..CMV promoter truncation led to the persistence of expression in the absence of E4, thus eliminating the ORF3 requirement...
  3. ncbi Inhibitory effect of cystic fibrosis sputum on adenovirus-mediated gene transfer in cultured epithelial cells
    M A Perricone
    Genzyme, Framingham, MA 01701, USA
    Hum Gene Ther 11:1997-2008. 2000
    ..We conclude that preexisting adenovirus-specific antibodies present in some of the patient samples were the predominant factor inhibiting Ad-mediated gene transfer...